Facing Litany of Litigation, Merck Offers $28M to Settle Fosamax ONJ Suits

Drug Industry Daily
A A
Merck Monday offered to pay out $27.7 million to settle nearly 1,200 personal injury lawsuits claiming its osteoporosis drug Fosamax caused jaw-bone deterioration known as osteonecrosis of the jaw (ONJ).

To View This Article:

Login

Subscribe To Drug Industry Daily